Skip to content

Biolivon publishes the science.

Biolivon
commentary

What happens after you stop a GLP-1 medicine

The most important question in metabolic medicine right now, and the least well answered.

Author
Biolivon Editorial
Published
29 Jul 2026
Last reviewed
29 Jul 2026

The full text of this piece is in editorial review and will publish here once it has cleared scientific, medical and compliance review. The reviewer panel and disclosures below are final.

Reviewed by

  • Not yet appointed
    MD, endocrinology — appointment pending · Biolivon Editorial Board
    Conflicts of interest: To be declared on appointment.
  • Not yet appointed
    MD — appointment pending · Biolivon Editorial Board
    Conflicts of interest: To be declared on appointment.

Reviewers check claims against sources. They are not responsible for editorial framing, and their review is not an endorsement of any product or practice.

This article is health information, not medical advice. If it changes what you are thinking of doing, take that thought to a qualified clinician before acting on it. Found an error? We publish corrections.